Approval · Notice of Compliance 7842 · 2006
STRATTERA: Notice of Compliance 7842
Issued March 28, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7842
- Date
- March 28, 2006
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monograph
- Therapeutic class
- Selective norepinephrine reuptake inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STRATTERA | Not yet assigned | — |
Medicinal ingredients
- ATOMOXETINE HYDROCHLORIDE 10 MG per CAP
- ATOMOXETINE HYDROCHLORIDE 18 MG per CAP
- ATOMOXETINE HYDROCHLORIDE 25 MG per CAP
- ATOMOXETINE HYDROCHLORIDE 40 MG per CAP
- ATOMOXETINE HYDROCHLORIDE 60 MG per CAP